Federal health officials have approved the first pill to treat all major forms of hepatitis C, the latest in a series of drug approvals that have reshaped treatment of the liver-destroying virus.
The proposal to change the way doctors are reimbursed for prescribing outpatient drugs has been criticized by lawmakers of both parties and by multiple patient and doctor groups.
Harvard Pilgrim will receive discounts on Novartis' congestive heart failure drug Entresto if the drug doesn't reach an agreed-upon reduction in hospitalizations. Under the Lilly agreement, Harvard Pilgrim has made the drugmaker's type 2 diabetes drug Trulicity a preferred drug in exchange for a...
Medicaid policies that only offer hepatitis C treatment to patients with advanced disease may be more costly and less effective than an unrestricted, full-access approach, according to a recent study.
Medicare's first step in reining in the skyrocketing cost of specialty drugs deserves support—something it has not received from hospitals, doctors, politicians or, of course, the pharmaceutical industry, which benefits the most from the status quo.
After 103 years, Novi, Mich.-based Frank W. Kerr Co., once one of the country's largest independent pharmaceutical wholesalers, is calling it quits.
An expert panel has recommended that the nasal form of the influenza vaccine should not be used for the upcoming flu season due to its lack of effectiveness over the past three years. AstraZeneca, the vaccine's manufacturer, generated more than $200 million in sales of FluMist in fiscal 2015.
President Barack Obama says he will veto a bill allowing purchases of over-the-counter medications from health savings accounts. Under current law, drug expenses are eligible only if prescribed by a physician.
As little as one free meal from a drug company can influence which medicines doctors prescribe for Medicare patients, according to a study using Medicare records and recently released data from the healthcare law's Open Payments program.
In deciding a case over who should have the upper hand in patent battles, the U.S. Supreme Court delivered a win to generic-drug makers and those hoping to hold down drug prices.
An experimental vaccine for the Zika virus is due to begin human testing in coming weeks, after getting the green light from U.S. health officials.
"Implied certification" can impose liability where a contractor has engaged in a lie by omission, such as failing to disclose its noncompliance. The decision could bring more False Claims Act cases against healthcare providers.